TATAA Biocenter appoints Johanna Nilsson as new Head of Marketing to strengthen scientific communication and client engagement
Comunicato Precedente
Comunicato Successivo
Johanna Nilsson brings seven years of comprehensive marketing experience, ranging from strategic planning to implementation. Most recently, she served at Kromnigon, a biotech company located at the heart of the BioVentureHub within the AstraZeneca R&D complex.
"It's an honor to join TATAA as Head of Marketing. TATAA is a company at the forefront of accelerating new modality drugs to market. Disorders that were incurable a decade ago, when I was pursuing my Ph.D., are now included in natal screening programs due to the availability of drugs. Being part of such transformative work is incredibly fulfilling", said Johanna Nilsson.
Johanna holds a Ph.D. focused on rare monogenetic metabolic muscle disorders from the University of Gothenburg, during which she contributed to high-impact publications in prestigious journals such as The New England Journal of Medicine and Annals of Neurology.
Read more about Johanna Nilsson, here.
CONTACT:
Martin Cooke, TATAA Biocenter, Marketing & Comms Specialist.
Email: martin.cooke@tataa.com
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/tataa-biocenter-appoints-johanna-nilsson-as-new-head-of-marketing-to-strengthen-scientific-communication-and-client-engagement-301944519.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
